BTMD stock icon

Biote Corp
BTMD

$6.63
6.59%
 

About: Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.

Employees: 194

0
Funds holding %
of 6,689 funds
0
Analysts bullish %
of 5 analysts
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

11% more capital invested

Capital invested by funds: $62.7M [Q4 2023] → $69.5M (+$6.74M) [Q1 2024]

0% more funds holding

Funds holding: 54 [Q4 2023] → 54 (+0) [Q1 2024]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q4 2023] → 2 (+0) [Q1 2024]

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

3.87% less ownership

Funds ownership: 37.41% [Q4 2023] → 33.53% (-3.87%) [Q1 2024]

26% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 19

Research analyst outlook

5 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$6.55
1%
downside
Avg. target
$8.11
22%
upside
High target
$9
36%
upside

5 analyst ratings

positive
100%
neutral
0%
negative
0%
Roth MKM
George Kelly
36%upside
$9
Buy
Reiterated
13 Mar 2024
B. Riley Securities
Jeff Van Sinderen
36%upside
$9
Buy
Initiated
20 Feb 2024
Jefferies
Kaumil Gajrawala
1%downside
$6.55
Buy
Initiated
1 Feb 2024
Truist Securities
Gregory Fraser
36%upside
$9
Buy
Maintained
18 Jan 2024
Roth MKM
George Kelly
6%upside
$7
Buy
Maintained
18 Jan 2024

Financial journalist opinion